n order to end an inquiry into whether Centene Corp.’s business operations violated Texas’ Medicaid fraud prevention law, the company will pay $165.6 million to the state.
With the signing of the deal, Texas becomes Centene’s 12th state to settle pharmacy billing disputes.
The largest Medicaid insurer in the country has paid out the most money in relation to its practises on drug pricing. The agreement was signed on July 11 but wasn’t made public until Monday after KHN started investigating after obtaining a copy of the settlement through a Texas public records request.
Numerous inquiries about the Texas settlement on Monday went unanswered by Centene. However, it has consistently denied wrongdoing in settlement agreements. Last year, Centene President and COO Brent Layton said that agreements in Ohio and Mississippi reflected the company’s “commitment to making the delivery of healthcare local, simple, and transparent” and allowed it to keep up its “relentless focus on delivering high-quality outcomes to our members.”